GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences

Author:

Fang Shuyi1,Li Kailing1,Shen Jikui2,Liu Sheng34,Liu Juli5,Yang Lei5ORCID,Hu Chang-Deng67,Wan Jun1348ORCID

Affiliation:

1. Department of BioHealth Informatics, School of Informatics and Computing, Indiana University–Purdue University Indianapolis, Indianapolis, IN, USA

2. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA

4. Collaborative Core for Cancer Bioinformatics (C3B) shared by Indiana University Simon Comprehensive Cancer Center and Purdue University Center for Cancer Research, Indianapolis, IN, USA

5. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA

6. Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA

7. Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN, USA

8. Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA

Abstract

Abstract The COVID-19 outbreak has become a global emergency since December 2019. Analysis of SARS-CoV-2 sequences can uncover single nucleotide variants (SNVs) and corresponding evolution patterns. The Global Evaluation of SARS-CoV-2/hCoV-19 Sequences (GESS, https://wan-bioinfo.shinyapps.io/GESS/) is a resource to provide comprehensive analysis results based on tens of thousands of high-coverage and high-quality SARS-CoV-2 complete genomes. The database allows user to browse, search and download SNVs at any individual or multiple SARS-CoV-2 genomic positions, or within a chosen genomic region or protein, or in certain country/area of interest. GESS reveals geographical distributions of SNVs around the world and across the states of USA, while exhibiting time-dependent patterns for SNV occurrences which reflect development of SARS-CoV-2 genomes. For each month, the top 100 SNVs that were firstly identified world-widely can be retrieved. GESS also explores SNVs occurring simultaneously with specific SNVs of user's interests. Furthermore, the database can be of great help to calibrate mutation rates and identify conserved genome regions. Taken together, GESS is a powerful resource and tool to monitor SARS-CoV-2 migration and evolution according to featured genomic variations. It provides potential directive information for prevalence prediction, related public health policy making, and vaccine designs.

Funder

National Institutes of Health

Walther Cancer Foundation

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference31 articles.

1. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients;Poh;Nat. Commun.,2020

2. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries;Yang;Emerg. Microbes Infect.,2020

3. Dissemination and co-circulation of SARS-CoV2 subclades exhibiting enhanced transmission associated with increased mortality in Western Europe and the United States;Hu,2020

4. A novel synonymous mutation of SARS-CoV-2: is this possible to affect their antigenicity and immunogenicity;Kim;Vaccines (Basel),2020

5. The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types;Daniloski,2020

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3